Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Right heart ventriculography using Gelifundol].

R Zotz1, L Duwe, R Erbel

  • 1II. Med. Klinik und Poliklinik, Johannes-Gutenberg-Universität, Mainz.

Zeitschrift Fur Kardiologie
|February 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classification of morphologic effects of percutaneous transluminal coronary angioplasty assessed by intravascular ultrasound.

The American journal of cardiology·1992
Same author

Relative sensitivity of four noninvasive methods in assessing systolic cardiovascular effects of isoproterenol in healthy volunteers.

Clinical pharmacology and therapeutics·1992
Same author

[Diagnostic goals in aortic dissection. Value of transthoracic and transesophageal echocardiography].

Herz·1992
Same author

Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes.

Biochemical pharmacology·1992
Same author

[Noninvasive quantification and classification of the severity of aortic stenosis using Doppler echocardiography].

Zeitschrift fur Kardiologie·1992
Same author

Gene order and genetic distance of 13 loci spanning murine chromosome 15.

Genomics·1992

Gelifundol is a safe contrast agent for echocardiography, improving diagnosis of right heart conditions like tricuspid insufficiency. It enhanced diagnostic accuracy in patients with suspected right ventricular lesions.

Area of Science:

  • Cardiology
  • Medical Imaging

Context:

  • Echocardiography is crucial for diagnosing right heart anomalies.
  • Assessing right ventricular lesions and tricuspid insufficiency requires effective contrast agents.

Purpose:

  • To evaluate the safety and efficacy of Gelifundol as a contrast agent in echocardiography for right heart assessment.
  • To determine if Gelifundol improves the diagnostic accuracy of right ventricular lesions and tricuspid insufficiency.

Summary:

  • Forty patients with suspected right heart anomalies received Gelifundol via intravenous injection during echocardiography.
  • Contrast echocardiograms were analyzed using subjective scoring and video-intensitometry.
  • Gelifundol demonstrated safety with no reported side effects or ECG changes, and significantly improved diagnostic accuracy, identifying previously undetected tricuspid insufficiency in 13 patients.

Related Experiment Videos

Impact:

  • Gelifundol is a safe and effective contrast agent for enhancing echocardiographic visualization of right heart structures.
  • The study supports the use of Gelifundol for improved diagnosis of right ventricular lesions and tricuspid insufficiency.
  • This enhances the diagnostic capabilities in cardiology, particularly for complex right heart pathologies.